These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 2056775)
1. Over-expression of lck in Burkitt's lymphoma cell lines. Jücker M; Abts H; Eick D; Lenoir GM; Tesch H Leukemia; 1991 Jun; 5(6):528-30. PubMed ID: 2056775 [No Abstract] [Full Text] [Related]
2. Antiimmunoglobulin inhibition of Burkitt's lymphoma cell proliferation and concurrent reduction of c-myc and mu heavy chain gene expression. Arasi VE; Lieberman R; Sandlund J; Kiwanuka J; Novikovs L; Kirsch I; Hollis G; Magrath IT Cancer Res; 1989 Jun; 49(12):3235-41. PubMed ID: 2497974 [TBL] [Abstract][Full Text] [Related]
3. fgr proto-oncogene mRNA induced in B lymphocytes by Epstein-Barr virus infection. Cheah MS; Ley TJ; Tronick SR; Robbins KC Nature; 1986 Jan 16-22; 319(6050):238-40. PubMed ID: 3003578 [TBL] [Abstract][Full Text] [Related]
4. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression. Wolf J; Pawlita M; Bullerdiek J; zur Hausen H Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373 [TBL] [Abstract][Full Text] [Related]
6. Regulation of c-fgr proto-oncogene expression in Burkitt's lymphoma cells: effect of interferon treatment and relationship to EBV status and c-myc mRNA levels. Sharp NA; Luscombe MJ; Clemens MJ Oncogene; 1989 Aug; 4(8):1043-6. PubMed ID: 2548145 [TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin heavy chain variable gene utilization in human large cell and Burkitt's lymphoma cell lines. Daley MD; Berinstein NL; Siminovitch KA Clin Invest Med; 1994 Dec; 17(6):522-30. PubMed ID: 7895416 [TBL] [Abstract][Full Text] [Related]
8. Anti-CD20- and B-cell receptor-mediated apoptosis: evidence for shared intracellular signaling pathways. Mathas S; Rickers A; Bommert K; Dörken B; Mapara MY Cancer Res; 2000 Dec; 60(24):7170-6. PubMed ID: 11156427 [TBL] [Abstract][Full Text] [Related]
9. Altered gene expression upon BCR cross-linking in Burkitt's lymphoma B cell line. Nakayama Y; Iwamoto Y; Maher SE; Tanaka Y; Bothwell AL Biochem Biophys Res Commun; 2000 Oct; 277(1):124-7. PubMed ID: 11027651 [TBL] [Abstract][Full Text] [Related]
10. The A-myb gene is preferentially expressed in tonsillar CD38+, CD39-, and sIgM- B lymphocytes and in Burkitt's lymphoma cell lines. Golay J; Erba E; Bernasconi S; Peri G; Introna M J Immunol; 1994 Jul; 153(2):543-53. PubMed ID: 8021494 [TBL] [Abstract][Full Text] [Related]
11. Regulation of c-myc expression by IFN in Burkitt's lymphoma cells. Salehzada T; Blanchard JM; Mechti N; Piechaczyk M; Dani C; Jeanteur P; Lebleu B Prog Clin Biol Res; 1985; 202():211-7. PubMed ID: 3832071 [No Abstract] [Full Text] [Related]
12. Comparative proteomic analysis implicates COMMD proteins as Epstein-Barr virus targets in the BL41 Burkitt's lymphoma cell line. Gkiafi Z; Panayotou G J Proteome Res; 2011 Jul; 10(7):2959-68. PubMed ID: 21615174 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of activation of HuBlym-1 gene unresolved. Devine JM Nature; 1986 May 22-28; 321(6068):437-9. PubMed ID: 3754934 [TBL] [Abstract][Full Text] [Related]
14. Cooperation between cellular and Epstein-Barr virus genes in the genesis of Burkitt's lymphoma. Calender A; Billaud M; Lenoir G IARC Sci Publ; 1988; (92):159-64. PubMed ID: 2853138 [No Abstract] [Full Text] [Related]
15. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. Hummel M; Bentink S; Berger H; Klapper W; Wessendorf S; Barth TF; Bernd HW; Cogliatti SB; Dierlamm J; Feller AC; Hansmann ML; Haralambieva E; Harder L; Hasenclever D; Kühn M; Lenze D; Lichter P; Martin-Subero JI; Möller P; Müller-Hermelink HK; Ott G; Parwaresch RM; Pott C; Rosenwald A; Rosolowski M; Schwaenen C; Stürzenhofecker B; Szczepanowski M; Trautmann H; Wacker HH; Spang R; Loeffler M; Trümper L; Stein H; Siebert R; N Engl J Med; 2006 Jun; 354(23):2419-30. PubMed ID: 16760442 [TBL] [Abstract][Full Text] [Related]
16. Antiproliferative function of p27kip1 is frequently inhibited in highly malignant Burkitt's lymphoma cells. Barnouin K; Fredersdorf S; Eddaoudi A; Mittnacht S; Pan LX; Du MQ; Lu X Oncogene; 1999 Nov; 18(46):6388-97. PubMed ID: 10597239 [TBL] [Abstract][Full Text] [Related]
17. The block of elongation in c-myc exon 1 is abolished in Burkitt's lymphoma cell lines with variant translocation. Eick D; Polack A; Kofler E; Bornkamm GW Oncogene; 1988 Oct; 3(4):397-403. PubMed ID: 3078949 [TBL] [Abstract][Full Text] [Related]
18. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines. Pokrovskaja K; Ehlin-Henriksson B; Bartkova J; Bartek J; Scuderi R; Szekely L; Wiman KG; Klein G Cell Growth Differ; 1996 Dec; 7(12):1723-32. PubMed ID: 8959341 [TBL] [Abstract][Full Text] [Related]
19. Somatic mutation and transcriptional deregulation of myc in endemic Burkitt's lymphoma disease: heptamer-nonamer recognition mistakes? Morse B; South VJ; Rothberg PG; Astrin SM Mol Cell Biol; 1989 Jan; 9(1):74-82. PubMed ID: 2927398 [TBL] [Abstract][Full Text] [Related]
20. Iron specific growth inhibition of Burkitt's lymphoma cells in vitro, associated with a decrease in translocated c-myc expression. Habel ME; Lemieux R; Jung D J Cell Physiol; 2005 Apr; 203(1):277-85. PubMed ID: 15468060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]